scispace - formally typeset
H

Hang Shi

Researcher at Jiangsu University

Publications -  5
Citations -  143

Hang Shi is an academic researcher from Jiangsu University. The author has contributed to research in topics: Web server & Wild type. The author has an hindex of 3, co-authored 4 publications receiving 69 citations.

Papers
More filters
Journal ArticleDOI

Blind prediction of homo- and hetero-protein complexes: The CASP13-CAPRI experiment.

Marc F. Lensink, +111 more
- 14 Oct 2019 - 
TL;DR: CAPRI Round 46 indicates that residues in binding interfaces were less well predicted in this set of targets than in previous Rounds, providing useful insights for directions of future improvements.
Journal ArticleDOI

Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment.

Marc F. Lensink, +113 more
- 28 Aug 2021 - 
TL;DR: The results of the CAPRI Round 50, the fourth joint CASP-CAPRI protein assembly prediction challenge, were reported in this paper, where the prediction performance was measured by a weighted scoring scheme that takes into account the number of models of acceptable quality or higher submitted by each group as part of their five top ranking models.
Journal ArticleDOI

Template-based modeling and ab-initio docking using CoDock in CAPRI.

TL;DR: This CAPRI edition showed that the hybrid docking strategy called CoDock can be efficiently adapted to the increasing variety of challenges in the field of molecular interactions.
Journal ArticleDOI

Molecular dynamics simulations of wild type and mutant of Pin1 peptidyl-prolyl isomerase

TL;DR: The structural stability analysis shows that the Cys113Asp mutation leads to the higher fluctuation of hydrophobic core in PPIase domain, which may help to understand the isomerisation mechanisms of Pin1.
Journal ArticleDOI

nCoVDock2: a docking server to predict the binding modes between COVID-19 targets and its potential ligands

TL;DR: Li et al. as mentioned in this paper presented nCoVDock2, a new docking server to predict the binding modes for targets from SARS-CoV-2, especially for the variants.